Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 21 August 2001
Vol. 2001, Issue 96, p. pe1
[DOI: 10.1126/stke.2001.96.pe1]

PERSPECTIVES

PODs in the Nuclear Spot: Enigmas in the Magician's Pot

Mitsutoki Hatta and Akiyoshi Fukamizu

The authors are at the Center for Tsukuba Advanced Research Alliance, Institute of Applied Biochemistry, University of Tsukuba, Tsukuba 305-8577, Japan. E-mail: akif{at}tara.tsukuba.ac.jp

Abstract: The promyelocytic leukemia (PML) nuclear body, also known as the PML oncogenic domain (POD), is implicated in the pathophysiology of PML. These nuclear subcompartments are dynamic structures. The PML protein, which undergoes a fusion event in patients with promyelocytic leukemia, is normally found in PODs. The PML protein may be a major regulator of the constituents of PODs, controlling POD organization and function. Hatta and Fukamizu describe the functions of PML and discuss how the POD structure and organization may be regulated and affect apoptosis, gene expression, and cellular transformation.

Citation: M. Hatta, A. Fukamizu, PODs in the Nuclear Spot: Enigmas in the Magician's Pot. Sci. STKE 2001, pe1 (2001).

Read the Full Text



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882